KR vs RYTM · P/E 19, rev $147.12B vs rev $130.1M
Kroger Company (KR) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
KR currently screens at market cap $46.17B and trailing P/E 19.0. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the KR and RYTM stock pages for the full models.
Not investment advice.